CD8A and colitis: Oral administration of A. muciniphila has shown significant improvement in symptoms in DSS-induced acute colitis (48), and it has been found to attenuate colitis-associated tumorigenesis by reducing infiltrating macrophages and CD8 cytotoxic T lymphocytes in the colon (49).